MEI Pharma Confirms Receipt of Unsolicited Acquisition Proposal – MEI Pharma (NA… – Press Release

MEI Pharma, Inc. MEIP (the “Company”) today confirmed receipt of an unsolicited and non-binding proposal on May 23, 2023 from a group represented by Anson Advisors Inc. and Cable Car Capital LLC, as referenced in their 13-D filing of earlier today, to acquire all outstanding shares of MEI for not less than $8.00 in cash per share, plus a contingent value right representing the right to receive 80% of the net proceeds payable from any license or disposition of the Company’s clinical assets.

Consistent with its fiduciary duties, MEI’s Board, in consultation with its independent financial and legal advisors, is reviewing the proposal from Anson Advisors and Cable Car Capital and will respond in due course. The board will pursue the course of action it believes is in the best interest of all MEI shareholders. MEI’s shareholders are advised that no action is necessary at this time.

The recommendation by the MEI Board to proceed with the pending Infinity Pharmaceuticals, Inc. transaction remains unchanged.

About MEI Pharma

MEI Pharma, Inc. MEIP is a pharmaceutical company focused on developing potential new therapies for cancer. MEI Pharma’s portfolio of drug candidates includes clinical stage candidates with differentiated mechanisms of action intended to address unmet medical needs and deliver improved benefit to patients, either as standalone treatments or in combination with other therapeutic options. For more information, please visit www.meipharma.com. Follow us on Twitter @MEI_Pharma and on LinkedIn.

Important Information about the Merger and Where to Find It

This communication relates to a proposed transaction between Infinity Pharmaceuticals, Inc. (“Infinity”) and MEI Pharma, Inc. (the “Company”). In connection with the proposed merger, the Company and Infinity plan to file with the SEC and mail or otherwise provide to their respective stockholders a joint proxy statement/prospectus regarding the proposed merger (as amended or supplemented from…

The post MEI Pharma Confirms Receipt of Unsolicited Acquisition Proposal – MEI Pharma (NA… – Press Release appeared first on CaymanMama.com.

from CaymanMama.com https://ift.tt/Fu2phGe